Colony »

Protagonist Therapeutics shares owned by Colony

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Colony from 13F filings

Historical chart of Colony investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Colony consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Colony

Quarter filed Position value Share count Share price at filing
2024-09-30 $19M 427k 45.00

More positions owned by Colony

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Ea Series Trust Ea Bridgeway Omn (BSVO)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Ishares Tr Core S&p Ttl Stk (ITOT)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Internatnal Val (DFIV)
Amazon (AMZN)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Ishares Tr Core Msci Total (IXUS)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Colony

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
BlackRock
Vanguard Group
Johnson & Johnson
State Street Corporation
Leucadia National Corporation
BVF
Pacer Advisors
Geode Capital Management
Perceptive Advisors
T. Rowe Price Associates
Kynam Capital Management
Invesco
Goldman Sachs Group

View all funds holding Protagonist Therapeutics